Not for treatment of Bordetella pertussis, Corynebacterium diphtheriae
, Clostridium tetani
or poliomyelitis infections. Do not administer intravascularly, intradermally, SC, or into the buttocks. Risk of syncope following vaccination. May not protect 100% of vaccinated persons. Postpone vaccination in case of an acute or febrile disease. Possible inj site hematoma in persons w/ any bleeding disorders (eg, haemophilia or thrombocytopenia, or in persons on anticoagulant therapy). Evaluate persons sensitive to the vaccine components for possibility of allergic reactions. Consider delaying of vaccination until completion of any immunosuppressive treatment. Not to be administered to individuals w/ progressive neurological disorder, uncontrolled epilepsy, or progressive encephalopathy until a treatment regimen has been established & condition has stabilized. Guillain-Barré syndrome that has occurred w/in 6 wk of receipt of prior vaccine containing tetanus toxoid. Pregnancy & lactation.